Global Top 10 Pharmaceutical Companies - Industry, Financial and SWOT Analysis

IntroductionBusiness description 34
This report analyzes the global pharmaceutical marketSWOT analysis 35
in terms of market size, key drivers and resistors,Strengths 35
trends and competitive positioning. It includes profiles ofWeaknesses 36
the top ten companies in the industry along with 5-yearOpportunities 37
financial analysis and in-depth SWOT analysis.Threats 38
ScopeRecent developments 38
*Performance of the global pharmaceutical market onF. Hoffmann-La Roche 40
the basis of sales, volume and respective growthCompany overview 40
patterns over the past five yearsBusiness description 40
*Obtain descriptive profiles of the top ten leadingSWOT analysis 41
players including strategic initiatives undertaken in theStrengths 41
last 12 monthsWeaknesses 41
*Analysis of the Strengths, Weaknesses, OpportunitiesOpportunities 42
and Threats of the top 10 pharmaceutical companiesThreats 43
along with business overview and financialsRecent developments 43
*Benchmark the performance of the top 10 players forNovartis 45
the past five years; includes revenue comparison,Company overview 45
profitability analysis, industry-specific ratiosBusiness description 45
HighlightsSWOT analysis 46
The global pharmaceutical market generated totalStrengths 46
revenues of $615.1 billion in 2008, representing aWeaknesses 47
compound annual growth rate (CAGR) of 4.7% forOpportunities 47
the period spanning 2004-2008.Threats 48
The cardiovascular segment was the market's mostRecent developments 48
lucrative in 2008, generating total revenues of $121.7Sanofi-Aventis 50
billion, equivalent to 19.8% of the market's overall value.Company overview 50
The performance of the market is forecast toBusiness description 50
decelerate, with an anticipated CAGR of 3.6% for theSWOT analysis 50
five-year period 2008-2013, which is expected to driveStrengths 50
the market to a value of $734 billion by the end ofWeaknesses 52
2013.Opportunities 53
Reasons to PurchaseThreats 54
*Save time, money and resources on analyzing theRecent developments 55
top 10 pharmaceutical companies using this reportAstraZeneca 57
*Analyze the global pharmaceutical market with keyCompany overview 57
industry metrics including market value, market volume,Business description 57
and growth forecastsSWOT analysis 58
*Assess the intensity of competition based on theStrengths 58
5-forces model including degree of rivalry, substitutes,Weaknesses 59
new entrants, buyer power and supplier powerOpportunities 60
Table of Contents :Threats 62
FIGURES 3Recent developments 62
Tables 4Abbott Laboratories 64
Executive Summary 5Company overview 64
Industry analysis 5Business description 64
Industry definition 5SWOT analysis 65
Research highlights 5Strengths 65
Top 10 companies landscape 5Weaknesses 66
Market value 7Opportunities 67
Market forecast 8Threats 67
Market segmentation-product 9Recent developments 68
Market segmentation-geographic 10Merck & Co., Inc. 70
Five Forces Analysis 11Company overview 70
Summary 11Business description 70
Buyer power 12SWOT analysis 71
Supplier power 13Strengths 71
New entrants 14Weaknesses 71
Substitutes 15Opportunities 72
Rivalry 16Threats 74
Top 10 Companies Landscape 17Recent developments 74
Overview 17Wyeth 77
Pfizer 18Company overview 77
GlaxoSmithKline 18Business description 77
F, Hoffmann-La Roche 19SWOT analysis 78
Novartis 19Strengths 78
Sanofi-Aventis 19Weaknesses 78
AstraZeneca 19Opportunities 79
Abbott Laboratories 19Threats 79
Merck & Co. 19Recent developments 79
Wyeth 20Bristol-Myers Squibb Company 82
Bristol-Myers Squibb Company 20Company overview 82
Revenue analysis 21Business description 82
Financial performance analysis 23SWOT analysis 83
Operating profit analysis 24Strengths 83
Net profit analysis 25Weaknesses 84
Ratio analysis 26Opportunities 84
Company Reports 28Threats 85
Pfizer Inc 28Recent developments 86
Company overview 28Five Year Financial Information 88
Business description 28Pfizer 88
SWOT analysis 29GlaxoSmithKline 91
Strengths 29F. Hoffman-La Roche 94
Weaknesses 29Novartis 97
Opportunities 30Sanofi-Aventis 100
Threats 31AstraZeneca 103
Recent developments 32Abbott Laboratories 106
GlaxoSmithKline Plc 34Merck & Co.
Company overview 34